Related Experiment Video

Updated: Jun 2, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
08:01

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

Published on: February 28, 2017

Expression of the active Notch1 decreases MTC tumor growth in vivo

Renata Jaskula-Sztul1, Pongthep Pisarnturakit, Michael Landowski

  • 1Department of Surgery Endocrine Surgery Research Laboratories, UW Carbone Cancer Center, University of Wisconsin, Madison, Wisconsin 53705, USA.

The Journal of Surgical Research
|May 17, 2011
PubMed
Abstract

Insights

Activating the Notch1 signaling pathway slowed medullary thyroid cancer (MTC) tumor growth in a mouse model. This therapeutic strategy reduced neuroendocrine markers, suggesting potential for MTC treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Medullary thyroid cancer (MTC) is a neuroendocrine tumor lacking curative therapies beyond surgery.
  • The Notch1 signaling pathway is typically absent in MTC.
  • Previous in vitro studies indicated Notch1 activation inhibits MTC cell growth and neuroendocrine markers.

Purpose of the Study:

  • To investigate the in vivo effects of Notch1 activation on medullary thyroid cancer growth and metastatic potential.
  • To assess the therapeutic efficacy of Notch1 pathway activation in a preclinical MTC model.

Main Methods:

  • A doxycycline-inducible Notch1 expression system was used in TT-NOTCH1 cells implanted in a murine subcutaneous xenograft model.
  • Notch1 expression was induced using doxycycline to study its effects on tumor development and growth.

Main Results:

  • Doxycycline-induced Notch1 activation significantly slowed tumor growth compared to control mice.
  • Western blot analysis confirmed Notch1 protein activation in treated tumors.
  • Activated Notch1 led to a significant reduction in key neuroendocrine markers: achaete-scute complex-like1 and chromogranin A.

Conclusions:

  • Activation of the Notch1 signaling pathway demonstrates therapeutic potential for medullary thyroid cancer.
  • Targeting Notch1 may represent a novel strategy for treating MTC patients.
  • In vivo validation supports Notch1 activation as a viable approach to reduce tumor progression and neuroendocrine characteristics in MTC.

More Related Videos

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...